NCT00001576View on ClinicalTrials.gov

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

March 31, 2002

Conditions
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
Interventions
DRUG

Melphalan

DRUG

Floxuridine

DRUG

Leucovorin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH